Triple-drug chemo fails to improve survival in advanced biliary tract cancer

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology showed that chemotherapy combining three different types of drugs did not improve overall survival for patients with advanced stage, inoperable biliary tract cancers.

Viz.ai, UCSF to Commercialize 3 Cardiac AI Algorithms

What You Should Know: – Viz.ai, an AI-powered disease detection and intelligent care coordination has signed an exclusive licensing agreement with University of California, San

September 1, 2023

Bayer expands Kerendia heart failure program to 15,000 patients as it plans to start three Phase III trials

Bayer is working on expanding the label for its chronic kidney disease drug Kerendia, announcing three new trials to investigate it as a treatment for

September 2, 2023

How SaaS platforms are breaking the mold for clinical trials

SaaS platform are changing what is possible in delivering clinical trials. Credit: Frau aus UA via Shutterstock. While the digitization of clinical trials has enabled

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.